SLC2A2 and diabetes mellitus: DM increased Slc2a2 mRNA, insulin treatment partially reduced it, but only the adjunctive treatment with resveratrol restored it to non-diabetic levels (DIR vs. DP, P < 0.001; DIR vs. DI P < 0.05I).